Eisai Co Ltd

Common Name
Eisai
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10,917
Ticker
4523
Exchange
TOKYO STOCK EXCHANGE
Description
Eisai Co., Ltd. is a prominent Japanese pharmaceutical company engaged in the research, development, manufacture, and marketing of healthcare products. Known for its significant contributions to drug ...

Eisai's Financial Statements Preview

Below are the financial statements of Eisai, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in trillions of JPY
2023 as of Not Specified
2022 as of Not Specified
2021 as of Not Specified
2020 as of Not Specified
2019 as of Not Specified
2018 as of Not Specified
Total assets
1.39a
1.26a
1.24a
1.09a
1.06a
1.07a
Equity attributable to owners of the parent
0.88a
0.8a
0.75a
0.7a
0.68a
0.63a
Non-controlling interests
0.02a
0.02a
0.02a
0.02a
0.02a
0.02a
Total liabilities
0.49a
0.44a
0.47a
0.36a
0.36a
0.42a
Download Data

Verified Sources Behind Eisai’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Eisai’s data sources below and access millions more through our Disclosure Search.

a. Eisai's Integrated Report 2024
a. Eisai's Integrated Report 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?